Skip to main content

Advertisement

SpringerLink
Log in

Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to characterize three new, recently established non-Hodgkin lymphoma cell lines (GUMBUS, DOGUM, and DOGKIT), isolated from patients developing high-clinical resistance to cytotoxic therapy, with respect to sensitivity toward 21 antitumor drugs from different classes of action, expression of three ABC transporters: P glycoprotein (Pgp) (MDR1 and ABCB1), multidrug resistance related proteins (MRP1) (ABCC1), and MRP2 (ABCC2), as well as a range of antioxidative enzymes and glutathione (GSH). The results were compared to analogous data from the well-known HL-60 and U-937 cells.

Methods

The MTT assay was used to measure cell growth inhibitory activity. Transporter expression was determined by using an electrophoresis/Western blot system. GSH and enzyme activities were measured by employing functional assays with photometric detection. Pre-incubation with hydrogen peroxide was chosen as a model for oxidative stress.

Results

Based on the 50% growth inhibitory values (GI50 values) of 21 known antitumor agents, the cell lines were sensitive again to chemotherapeutics after being in culture for at least 15-18 weeks. DOGUM and DOGKIT were most sensitive toward antitumor drugs in in vitro cytotoxicity assays while DOGUM was the least sensitive. None of the cell lines expressed measurable levels of any of the three transporters investigated and showed only moderate variation in their antioxidative defense system. After pre-treatment with hydrogen peroxide, GSH peroxidase (GPx) activity increased and, in general, a decrease in the growth inhibitory activities of various platinum antitumor agents occurred. Furthermore, all three cell lines rapidly acquired resistance to doxorubicin, methotrexate, and cisplatin again in vitro after only 3–5 treatment cycles with the respective drug.

Conclusions

The therapy-resistant lymphoma cell lines GUMBUS, DOGUM, and DOGKIT were sensitive to antitumor agents once again after they had been established in culture. However, their sensitivity to antitumor agents can be rapidly decreased in vitro by either introducing the cells to culture conditions favoring oxidative stress or by exposing the cells at regular intervals to an antitumor drug. The ability of these three cell lines to quickly adapt to toxic insults in their environment is probably the reason why clinical resistance occurred.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ahmad S (1995) Antioxidant mechanisms of enzymes and proteins. In: Ahmad S (ed) Oxidative stress and antioxidant defences in biology, 1st edn. Chapman and Hall, London, pp 238–265

    Google Scholar 

  • Akman SA, Forrest G, Chu F-F, Esworthy RS, Doroshow JH (1990) Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant mcf-7 breast cancer cells. Cancer Res 50:1397–1402

    PubMed  CAS  Google Scholar 

  • Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR (2007) Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood 109: 3409–3416

    Article  PubMed  CAS  Google Scholar 

  • Baud O, Green AE, Li J, Wang H, Volpe JL, Rosenberg PA (2004) Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. Neuroscience 24:1531–1540

    Article  PubMed  CAS  Google Scholar 

  • Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Biol Chem 195:133–140

    CAS  Google Scholar 

  • Boubakari, Bracht K, Neumann C, Grünert R, Bednarski PJ (2004) No Correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes. Arch Pharm Pharm Med Chem 337:668–671

    Article  CAS  Google Scholar 

  • Bracht K, Boubakari, Grünert R, Bednarski PJ (2006) Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data. Anticancer Drugs 17:41–51

    Article  PubMed  CAS  Google Scholar 

  • Bracht K, Liebeke M, Ritter CA, Grünert R, Bednarski PJ (2007) Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ABC transporters: Comparison with the NCI data. Anti-Cancer Drugs 18:389–404

    Article  PubMed  CAS  Google Scholar 

  • Candoni A, Damiani D, Michelutti A, Masolini P, Michieli M, Michelutti T, Geromin A, Fanin R (2003) Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia. Eur J Haematol 71:1–8

    Article  PubMed  CAS  Google Scholar 

  • Damiani D, Tiribelli M, Calistri E, Geromin A, Chiarvesio A, Michelutti A, Cavallin M, Fanin R (2006) The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype. Haematologica 91:825–828

    PubMed  CAS  Google Scholar 

  • Dirven HAAM, Dictus ELJT, Broeders NLHL, Ommen Bv, Bladeren PJv (1995) The role of human glutathione S-transferase isoenzymes in the formation of glutathione konjugates of the alkylating cytostatic drug thiotepa. Cancer Res 55:1701–1706

    PubMed  CAS  Google Scholar 

  • Dölken L, Schüler F, Dölken G (1998) Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques 25:1058–1064

    PubMed  Google Scholar 

  • Farber CM, Kanganis DN, Liebes LF, Silber R (1989) Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity ib CLL B lymphocytes. Br J Haematol 72:32–35

    PubMed  CAS  Google Scholar 

  • Flescher E, Tripoli H, Salnikow K, Burns FJ (1998) Oxidative stress suppresses transcription factor activities in stimulated lymphocytes. J Clin Exp Immunol 112:242–247

    Article  CAS  Google Scholar 

  • Gottesman MJ, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427

    Article  PubMed  CAS  Google Scholar 

  • Güner G, Islekel H, Oto Ö, Hazan E, Acikel Ü (1996) Evaluation of some antioxidant enzymes in lung carcinoma tissue. Cancer Lett 103:233–239

    Article  PubMed  Google Scholar 

  • Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferase. Biol Chem 249:7130–7139

    CAS  Google Scholar 

  • Holmgren A, Björnstedt M (1995) Thioredoxin and Thioredoxin Reductase. Methods Enzymol 252:199–208

    Article  PubMed  CAS  Google Scholar 

  • Jacobs WLW (1971) A colorimetric assay for g-glutamyltranspeptidase. Clin Chim Acta 31:175–179

    Article  PubMed  CAS  Google Scholar 

  • Jönsson K, Dahlberg N, Tidefelt U, Paul C, Andersson G (1995) Characterization on an anthracylcline-resistant human promyelocytic leukemia (HL-60) cell line with an elevated MDR-1 Gene Expression. Biochem Pharmacol 49:755–762

    Article  PubMed  Google Scholar 

  • Katoch B, Begum R (2003) Biochemical basis of the high resistance to oxidative stress in Dictyostelium discoideum. J Biosci 28:581–588

    Article  PubMed  CAS  Google Scholar 

  • Kerb R, Hoffmeyer S, Brinkmann U (2001) ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1, MRP2. Pharmacogenomics 2:51–64

    Article  PubMed  CAS  Google Scholar 

  • Koistinen P, Ruuska S, Säily M, Siitonen P, Siitonen T, Savolainen MJ, Kinnula VL, Savolainen E-R (2006) An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia. Haematologica 91:829–832

    PubMed  CAS  Google Scholar 

  • Laupeze B, Amiot L, Drenou B, Bernard M, Branger B, Grosset JM, Lamy T, Fauchet R, Fardel O (2002) High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival. Br J Haematol 116:834–838

    Article  PubMed  CAS  Google Scholar 

  • Legrand O, Simonin G, Perrot J-Y, Zittoun R, Marie J-P (1998) Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 91:4480–4488

    PubMed  CAS  Google Scholar 

  • Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, Bracci PM, Roman E, Smith MT, Holly EA (2006) Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodkin´s lymphoma. Haematologica 91:1222–1227

    PubMed  CAS  Google Scholar 

  • Litman T, Druley T, Stein W, Bates S (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931–959

    Article  PubMed  CAS  Google Scholar 

  • Mansson E, Paul A, Löfgren C, Ullberg K, Paul C, Eriksson S, Albertioni F (2001) Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy. Br J Haematol 114:557–565

    Article  PubMed  CAS  Google Scholar 

  • Mantovani G, Macció A, Madeddu C, Mura L, Gramignan G, Lusso MR, Murgia V, Camboni P, Ferreli L, Mocci M, Massa E (2003) The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic Res 37:213–223

    Article  PubMed  CAS  Google Scholar 

  • Meilhac O, Zho M, Santaman N, Parthasarathy S (2000) Lipid peroxides induce expression of catalase in cultured vacular cells. J Lipid Res 41:1205–1213

    PubMed  CAS  Google Scholar 

  • Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  PubMed  CAS  Google Scholar 

  • Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346:1–8

    Article  PubMed  CAS  Google Scholar 

  • Neumann C, Boubakari, Grünert R, Bednarski PJ (2003) Nicotinamide adenine dinucleotide phosphate-regenerating system coupled to a glutathione-reductase microtiter method for determination of total glutathione concentrations in adherent growing cancer cell lines. Anal Biochem 320:170–178

    Article  PubMed  CAS  Google Scholar 

  • O’Brien ML, Tew KD (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A:967–978

    Article  PubMed  CAS  Google Scholar 

  • Paglia DE, Vallentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

    PubMed  CAS  Google Scholar 

  • Rinke K, Grünert R, Bednarski PJ (2001) New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione. Pharmazie 56:763–769

    PubMed  CAS  Google Scholar 

  • Ritter CA (2005) Transportproteine vermitteln Resistenzen. Pharm Z 150:16–21

    CAS  Google Scholar 

  • RKI (2006) Krebs in Deutschland—Häufigkeiten und Trends, 5. Auflage ed. Gesellschaft der epidemiologischen Krebsregister Deutschland e.V. in Zusammenarbeit mit dem Robert-Koch-Institut

  • Saito Y, Yoshida Y, Akazawa T, Takahashi K, Niki E (2003) Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem 278:39426–39434

    Google Scholar 

  • Short MD, Xie Y, Li L, Cassidy PB, Roberts JC (2003) Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxide induction in V79 cells. J Med Chem 46:3308–3313

    Article  PubMed  CAS  Google Scholar 

  • Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nature Rev: Drug Discov 5:219–234

    Article  CAS  Google Scholar 

  • Szasz G (1969) A kinetic photometric method for serum g-glutamyl transpeptidase. Clin Chem 15:124–136

    PubMed  CAS  Google Scholar 

  • Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313–4320

    PubMed  CAS  Google Scholar 

  • Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood other tissues. Anal Biochem 27:502–522

    Article  PubMed  CAS  Google Scholar 

  • Tome ME, Johnson DBF, Rimsza LM, Roberts RA, Grogan TM, Miller TP, Oberly LW, Briehl MM (2005) A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 106:3594–3601

    Article  PubMed  CAS  Google Scholar 

  • Zhan Z, Sandor VA, Gamelin E, Regis J, Dickstein B, Wilson W, Fojo AT, Bates SE (1997) Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay. Blood 89:3795–3800

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Prof. Dr. R. Siebert and Dr. L. Harder (Institut für Humangenetik, Campus Kiel des Universitätsklinikums Schleswig-Holstein, Kiel, Germany) for providing the cytogenetic data on the new cell lines and thank E. Böttcher and K. Gumm for technical assistance. We also thank Pharmacia-Upjohn, Sanofi-Synthelabo, and Riemser Arzneimittel AG for gifts of doxorubicin, oxaliplatin, and oxoplatin, respectively.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, F.-L. Jahnstrasse, 17487, Greifswald, Germany

    Karin Bracht & Patrick J. Bednarski

  2. Department of Hematology and Oncology, University of Greifswald, 17475, Greifswald, Germany

    Thomas Kiefer & Gottfried Dölken

Authors
  1. Karin Bracht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Kiefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gottfried Dölken
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick J. Bednarski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick J. Bednarski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bracht, K., Kiefer, T., Dölken, G. et al. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status. J Cancer Res Clin Oncol 133, 957–967 (2007). https://doi.org/10.1007/s00432-007-0241-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-007-0241-x

Keywords

Search

Navigation